Want to join the conversation?
$CELG 2Q15 Call: ABRAXANE posted strong 9% sequential growth & 13% year-over-year growth driven primarily by ongoing launch of pancreatic cancer across Europe. We also launched ABRAXANE in non-small-cell lung cancer in Europe. We expect solid future growth in Europe for ABRAXANE.
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.
$RAI has received a $47 billion take over offer from British tobacco giant British American Tobacco! This is huge!